Table 2. Cohort Characteristics by Outcome.

	Total n = 195	Good Outcome n (%) 73 (37)	Poor Outcome n (%) 122 (63)	p
Demographics
Age
<2 yr	86	31 (36)	55 (64)	0.93
2–11 yr	69	27 (39)	42 (61)
12–18 yr	40	15 (38)	25 (63)
Gender
Male	125	48 (38)	77 (62)	0.71
Female	70	25 (36)	45 (64)
Baseline Pediatric Cerebral Performance Category
1–2	161	64 (40)	97 (60)	0.15
3–5	34	9 (26)	25 (74)
Preexisting condition
Yes	138	59 (43)	79 (57)	0.02
No	57	14 (25)	43 (75)
Cardiac arrest details
Location
In-hospital in an ICU	86	46 (53)	40 (47)	<0.0001
In-hospital not in an ICU	49	19 (39)	30 (61)
Out of hospital	58	7 (12)	51 (88)
Etiology
Cardiac	103	48 (47)	55 (53)	0.003
Respiratory	90	35 (39)	55 (61)	0.57
Rhythm
Asystole	85	14 (16)	71 (84)	<0.001
Ventricular tachycardia/ventricular fibrillation	16	9 (56)	7 (44)
Other	66	40 (61)	26 (39)
Epinephrine doses
0	18	10 (56)	8 (44)	0.02
1	45	23 (51)	22 (49)
2	34	15 (44)	19 (56)
3	37	8 (22)	29 (78)
4+	54	16 (30)	38 (70)
Postarrest features
Pao2
Hyperoxia	87	30 (34)	57 (66)	0.57
Normoxia	66	29 (44)	37 (56)
Hypoxia	22	8 (36)	14 (64)
Hyperoxia and hypoxia	20	6 (30)	14 (70)
Paco2
Hyperventilation	48	16 (33)	32 (67)	0.26
Normoventilation	57	27 (47)	30 (53)
Hypoventilation	64	23 (36)	41 (64)
Hyperventilation and hypoventilation	26	7 (27)	19 (73)
Spontaneous hypothermia	84	20 (24)	64 (76)	<0.001
Hyperglycemia	96	25 (26)	71 (74)	0.002
Survival
PICU discharge	89	73 (82)	16 (18)
Hospital discharge	89	73 (82)	16 (18)

Row percentages are shown.